1. Home
  2. LCII vs KNSA Comparison

LCII vs KNSA Comparison

Compare LCII & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LCII
  • KNSA
  • Stock Information
  • Founded
  • LCII 1956
  • KNSA 2015
  • Country
  • LCII United States
  • KNSA United Kingdom
  • Employees
  • LCII N/A
  • KNSA N/A
  • Industry
  • LCII Auto Parts:O.E.M.
  • KNSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • LCII Consumer Discretionary
  • KNSA Health Care
  • Exchange
  • LCII Nasdaq
  • KNSA Nasdaq
  • Market Cap
  • LCII 2.3B
  • KNSA 2.6B
  • IPO Year
  • LCII N/A
  • KNSA 2018
  • Fundamental
  • Price
  • LCII $88.00
  • KNSA $38.70
  • Analyst Decision
  • LCII Hold
  • KNSA Strong Buy
  • Analyst Count
  • LCII 3
  • KNSA 7
  • Target Price
  • LCII $90.33
  • KNSA $46.86
  • AVG Volume (30 Days)
  • LCII 242.5K
  • KNSA 395.7K
  • Earning Date
  • LCII 10-30-2025
  • KNSA 10-28-2025
  • Dividend Yield
  • LCII 5.24%
  • KNSA N/A
  • EPS Growth
  • LCII 25.42
  • KNSA N/A
  • EPS
  • LCII 5.97
  • KNSA 0.07
  • Revenue
  • LCII $3,871,475,000.00
  • KNSA $529,332,000.00
  • Revenue This Year
  • LCII $7.80
  • KNSA $37.21
  • Revenue Next Year
  • LCII $4.31
  • KNSA $12.07
  • P/E Ratio
  • LCII $14.71
  • KNSA $585.89
  • Revenue Growth
  • LCII 1.36
  • KNSA 56.18
  • 52 Week Low
  • LCII $72.31
  • KNSA $17.82
  • 52 Week High
  • LCII $129.38
  • KNSA $39.43
  • Technical
  • Relative Strength Index (RSI)
  • LCII 36.24
  • KNSA 62.12
  • Support Level
  • LCII $85.87
  • KNSA $36.80
  • Resistance Level
  • LCII $88.65
  • KNSA $39.39
  • Average True Range (ATR)
  • LCII 2.32
  • KNSA 1.13
  • MACD
  • LCII -0.13
  • KNSA -0.10
  • Stochastic Oscillator
  • LCII 31.92
  • KNSA 75.86

About LCII LCI Industries

LCI Industries Inc supplies domestically and internationally components for the original equipment manufacturers of recreational vehicles and adjacent industries including buses; and trailers used to haul boats, livestock, equipment, and other cargo. It has two reportable segments; the original equipment manufacturers segment and the aftermarket segment. The OEM Segment manufactures or distributes components for the OEMs of RVs and adjacent industries, including buses; trailers used to haul boats, livestock, equipment, and other cargo; trucks; pontoon boats; trains; manufactured homes; and modular housing. Its products are sold to manufacturers of RVs such as Thor Industries, Forest River, Winnebago, and other RV OEMs, and to manufacturers in adjacent industries.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Share on Social Networks: